A precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for the majority of colorectal cancer patients, according to new research ...

The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found. The study, led by Dr. Rod Bremner, a Senior Investigator at the ...

Explore cancer drug resistance and its significant impact on treatment options and patient outcomes in modern cancer therapy.

CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...

KYOTO -- A team of researchers in Japan has uncovered the mechanism by which caffeic acid, a polyphenol found in coffee, ...

A metabolic enzyme studied for over seven decades has a hidden second function - it can unwind RNA and promote cell cycle ...

New research shows how cancer cells use a vitamin B7-dependent pathway to survive in the absence of glutamine, revealing potential drug targets.

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...